Clinical Pharmacologists Warn of DTC Genomics Backlash on PGx

The American College of Clinical Pharmacy has called for federal oversight of direct-to-consumer genomic tests in order to prevent "stigmatizing" all gene-based tests.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.